MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-06-30, APDN had -$1,690,960 decrease in cash & cash equivalents over the period.

Cash Flow Overview

Change in Cash
-$1,690,960
Unit: Dollar
Positive Cash Flow Breakdown
    • Net proceeds from issuance of co...
    • Net proceeds from exercise of wa...
    • Prepaid expenses, other current ...
    • Others
Negative Cash Flow Breakdown
    • Net loss from continuing operati...
    • Unrealized gain on change in fai...
    • Purchase of property and equipme...
    • Others

Cash Flow
2025-06-30
Stock-based compensation
80,373
Change in provision for bad debts
5,423
Prepaid expenses, other current assets and deposits
-417,738
Inventories
-94,002
Accounts receivable
-33,782
Accounts payable and accrued liabilities
-172,657
Net loss from continuing operations
-9,585,822
Depreciation and amortization
255,601
Loss on write-off of property and equipment
5,212
Unrealized gain on change in fair value of warrants classified as a liability
318,840
Deferred revenue
43,500
Net cash used in operating activities from continuing operations
-9,141,688
Purchase of property and equipment
313,121
Net cash used in investing activities from continuing operations
-313,121
Net proceeds from exercise of warrants
2,215,828
Net proceeds from issuance of common stock and pre-funded warrants
5,712,700
Net cash provided by financing activities from continuing operations
7,928,528
Cash used in operating activities
-185,679
Cash provided by investing activities
21,000
Net cash used by discontinued operations
-164,679
Net (decrease) increase in cash, cash equivalents and restricted cash
-1,690,960
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Net proceeds fromissuance of common stock...$5,712,700 Net proceeds fromexercise of warrants$2,215,828 Net cash provided byfinancing activities from...$7,928,528 Net (decrease)increase in cash, cash...-$1,690,960 Canceled cashflow$7,928,528 Prepaid expenses, othercurrent assets and...-$417,738 Depreciation andamortization$255,601 Inventories-$94,002 Stock-based compensation$80,373 Deferred revenue$43,500 Accounts receivable-$33,782 Change in provision forbad debts$5,423 Loss on write-off ofproperty and equipment$5,212 Cash provided byinvesting activities$21,000 Net cash used inoperating activities from...-$9,141,688 Canceled cashflow$935,631 Net cash used ininvesting activities from...-$313,121 Net cash used bydiscontinued operations-$164,679 Canceled cashflow$21,000 Net loss fromcontinuing operations-$9,585,822 Unrealized gain on change infair value of...$318,840 Accounts payable andaccrued liabilities-$172,657 Purchase of property andequipment$313,121 Cash used inoperating activities-$185,679

APPLIED DNA SCIENCES INC (APDN)

APPLIED DNA SCIENCES INC (APDN)